Jump to content

Systematic review

This article has been published in the peer-reviewed journal WikiJournal of Medicine (2020). Click to view the published version.
From Wikipedia, the free encyclopedia
(Redirected from Systematic Review)
For the academic journal, see Systematic Reviews (journal).

A systematic review is considered the most trusted form of evidence
Part of a series on
Research
A laptop computer next to archival materials
Research design
Research strategy
Philosophical schools
Methodology
Methods
Tools and software
Philosophy portal

A systematic review is a scholarly synthesis of the evidence on a clearly presented topic using critical methods to identify, define and assess research on the topic.[1] A systematic review extracts and interprets data from published studies on the topic (in the scientific literature), then analyzes, describes, critically appraises and summarizes interpretations into a refined evidence-based conclusion.[1][2] For example, a systematic review of randomized controlled trials is a way of summarizing and implementing evidence-based medicine.[3]

While a systematic review may be applied in the biomedical or health care context, it may also be used where an assessment of a precisely defined subject can advance understanding in a field of research.[4] A systematic review may examine clinical tests, public health interventions, environmental interventions,[5] social interventions, adverse effects, qualitative evidence syntheses, methodological reviews, policy reviews, and economic evaluations.[6][7]

Systematic reviews are closely related to meta-analyses, and often the same instance will combine both (being published with a subtitle of "a systematic review and meta-analysis"). The distinction between the two is that a meta-analysis uses statistical methods to induce a single number from the pooled data set (such as an effect size), whereas the strict definition of a systematic review excludes that step. However, in practice, when one is mentioned, the other may often be involved, as it takes a systematic review to assemble the information that a meta-analysis analyzes, and people sometimes refer to an instance as a systematic review, even if it includes the meta-analytical component.

An understanding of systematic reviews and how to implement them in practice is common for professionals in health care, public health, and public policy.[1]

Systematic reviews contrast with a type of review often called a narrative review. Systematic reviews and narrative reviews both review the literature (the scientific literature), but the term literature review without further specification refers to a narrative review.

Characteristics

[edit]

A systematic review can be designed to provide a thorough summary of current literature relevant to a research question.[1] A systematic review uses a rigorous and transparent approach for research synthesis, with the aim of assessing and, where possible, minimizing bias in the findings. While many systematic reviews are based on an explicit quantitative meta-analysis of available data, there are also qualitative reviews and other types of mixed-methods reviews that adhere to standards for gathering, analyzing, and reporting evidence.[8]

Systematic reviews of quantitative data or mixed-method reviews sometimes use statistical techniques (meta-analysis) to combine results of eligible studies. Scoring levels are sometimes used to rate the quality of the evidence depending on the methodology used, although this is discouraged by the Cochrane Library.[9] As evidence rating can be subjective, multiple people may be consulted to resolve any scoring differences between how evidence is rated.[10][11][12]

The EPPI-Centre, Cochrane, and the Joanna Briggs Institute have been influential in developing methods for combining both qualitative and quantitative research in systematic reviews.[13][14][15] Several reporting guidelines exist to standardise reporting about how systematic reviews are conducted. Such reporting guidelines are not quality assessment or appraisal tools. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement[16] suggests a standardized way to ensure a transparent and complete reporting of systematic reviews, and is now required for this kind of research by more than 170 medical journals worldwide.[17] The latest version of this commonly used statement corresponds to PRISMA 2020 (the respective article was published in 2021).[18] Several specialized PRISMA guideline extensions have been developed to support particular types of studies or aspects of the review process, including PRISMA-P for review protocols and PRISMA-ScR for scoping reviews.[17] A list of PRISMA guideline extensions is hosted by the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network.[19] However, the PRISMA guidelines have been found to be limited to intervention research and the guidelines have to be changed in order to fit non-intervention research. As a result, Non-Interventional, Reproducible, and Open (NIRO) Systematic Reviews was created to counter this limitation.[20]

For qualitative reviews, reporting guidelines include ENTREQ (Enhancing transparency in reporting the synthesis of qualitative research) for qualitative evidence syntheses; RAMESES (Realist And MEta-narrative Evidence Syntheses: Evolving Standards) for meta-narrative and realist reviews;[21][22] and eMERGe (Improving reporting of Meta-Ethnography) for meta-ethnograph.[13]

Developments in systematic reviews during the 21st century included realist reviews and the meta-narrative approach, both of which addressed problems of variation in methods and heterogeneity existing on some subjects.[23][24]

Types

[edit]

There are over 30 types of systematic review and Table 1 below non-exhaustingly summarises some of these.[17][16] There is not always consensus on the boundaries and distinctions between the approaches described below.

Table 1: A summary of some of the types of systematic review
Review type Summary
Mapping review/systematic map A mapping review maps existing literature and categorizes data. The method characterizes the quantity and quality of literature, including by study design and other features. Mapping reviews can be used to identify the need for primary or secondary research.[17]
Meta-analysis A meta-analysis is a statistical analysis that combines the results of multiple quantitative studies. Using statistical methods, results are combined to provide evidence from multiple studies. The two types of data generally used for meta-analysis in health research are individual participant data and aggregate data (such as odds ratios or relative risks).
Mixed studies review/mixed methods review Refers to any combination of methods where one significant stage is a literature review (often systematic). It can also refer to a combination of review approaches, such as combining quantitative with qualitative research.[17]
Qualitative systematic review/qualitative evidence synthesis This method integrates or compares findings from qualitative studies. The method can include 'coding' the data and looking for 'themes' or 'constructs' across studies. Multiple authors may improve the 'validity' of the data by potentially reducing individual bias.[17]
Rapid review An assessment of what is already known about a policy or practice issue, which uses systematic review methods to search for and critically appraise existing research. Rapid reviews are still a systematic review, however parts of the process may be simplified or omitted in order to increase rapidity.[25] Rapid reviews were used during the COVID-19 pandemic.[26]
Systematic review A systematic search for data using a repeatable method. It includes appraising the data (for example, the quality of the data) and a synthesis of research data.
Systematic search and review Combines methods from a 'critical review' with a comprehensive search process. This review type is usually used to address broad questions to produce the most appropriate evidence synthesis. This method may or may not include quality assessment of data sources.[17]
Systematized review Include elements of the systematic review process, but searching is often not as comprehensive as a systematic review and may not include quality assessments of data sources.

Scoping reviews

[edit]

Scoping reviews are distinct from systematic reviews in several ways. A scoping review is an attempt to search for concepts by mapping the language and data which surrounds those concepts and adjusting the search method iteratively to synthesize evidence and assess the scope of an area of inquiry.[23][24] This can mean that the concept search and method (including data extraction, organisation and analysis) are refined throughout the process, sometimes requiring deviations from any protocol or original research plan.[27][28] A scoping review may often be a preliminary stage before a systematic review, which 'scopes' out an area of inquiry and maps the language and key concepts to determine if a systematic review is possible or appropriate, or to lay the groundwork for a full systematic review. The goal can be to assess how much data or evidence is available regarding a certain area of interest.[27][29] This process is further complicated if it is mapping concepts across multiple languages or cultures.

As a scoping review should be systematically conducted and reported (with a transparent and repeatable method), some academic publishers categorize them as a kind of 'systematic review', which may cause confusion. Scoping reviews are helpful when it is not possible to carry out a systematic synthesis of research findings, for example, when there are no published clinical trials in the area of inquiry. Scoping reviews are helpful when determining if it is possible or appropriate to carry out a systematic review, and are a useful method when an area of inquiry is very broad,[30] for example, exploring how the public are involved in all stages systematic reviews.[31]

There is still a lack of clarity when defining the exact method of a scoping review as it is both an iterative process and is still relatively new.[32] There have been several attempts to improve the standardisation of the method,[28][27][29][33] for example via a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline extension for scoping reviews (PRISMA-ScR).[34] PROSPERO (the International Prospective Register of Systematic Reviews) does not permit the submission of protocols of scoping reviews,[35] although some journals will publish protocols for scoping reviews.[31]

Stages

[edit]

While there are multiple kinds of systematic review methods, the main stages of a review can be summarised as follows:

Defining the research question

[edit]

Some reported that the 'best practices' involve 'defining an answerable question' and publishing the protocol of the review before initiating it to reduce the risk of unplanned research duplication and to enable transparency and consistency between methodology and protocol.[36][37] Clinical reviews of quantitative data are often structured using the mnemonic PICO, which stands for 'Population or Problem', 'Intervention or Exposure', 'Comparison', and 'Outcome', with other variations existing for other kinds of research. For qualitative reviews, PICo is 'Population or Problem', 'Interest', and 'Context'.

Searching for sources

[edit]

Relevant criteria can include selecting research that is of good quality and answers the defined question.[36] The search strategy should be designed to retrieve literature that matches the protocol's specified inclusion and exclusion criteria. The methodology section of a systematic review should list all of the databases and citation indices that were searched. The titles and abstracts of identified articles can be checked against predetermined criteria for eligibility and relevance. Each included study may be assigned an objective assessment of methodological quality, preferably by using methods conforming to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement,[19] or the standards of Cochrane.[38]

Common information sources used in searches include scholarly databases of peer-reviewed articles such as MEDLINE, Web of Science, Embase, and PubMed, as well as sources of unpublished literature such as clinical trial registries and grey literature collections. Key references can also be yielded through additional methods such as citation searching, reference list checking (related to a search method called 'pearl growing'), manually searching information sources not indexed in the major electronic databases (sometimes called 'hand-searching'),[39] and directly contacting experts in the field.[40]

To be systematic, searchers must use a combination of search skills and tools such as database subject headings, keyword searching, Boolean operators, and proximity searching while attempting to balance sensitivity (systematicity) and precision (accuracy). Inviting and involving an experienced information professional or librarian can improve the quality of systematic review search strategies and reporting.[41][42][43][44][45]

'Extraction' of relevant data

[edit]
A visualisation of data being 'extracted' and 'combined' in a Cochrane intervention effect review where a meta-analysis is possible[46]

Relevant data are 'extracted' from the data sources according to the review method. The data extraction method is specific to the kind of data, and data extracted on 'outcomes' is only relevant to certain types of reviews. For example, a systematic review of clinical trials might extract data about how the research was done (often called the method or 'intervention'), who participated in the research (including how many people), how it was paid for (for example, funding sources) and what happened (the outcomes).[36] Relevant data are being extracted and 'combined' in an intervention effect review, where a meta-analysis is possible.[46]

Assess the eligibility of the data

[edit]

This stage involves assessing the eligibility of data for inclusion in the review by judging it against criteria identified at the first stage.[36] This can include assessing if a data source meets the eligibility criteria and recording why decisions about inclusion or exclusion in the review were made. Software programmes can be used to support the selection process, including text mining tools and machine learning, which can automate aspects of the process.[47] The 'Systematic Review Toolbox' is a community-driven, web-based catalog of tools, to help reviewers chose appropriate tools for reviews.[48]

Analyse and combine the data

[edit]

Analysing and combining data can provide an overall result from all the data. Because this combined result may use qualitative or quantitative data from all eligible sources of data, it is considered more reliable as it provides better evidence, as the more data included in reviews, the more confident we can be of conclusions. When appropriate, some systematic reviews include a meta-analysis, which uses statistical methods to combine data from multiple sources. A review might use quantitative data, or might employ a qualitative meta-synthesis, which synthesises data from qualitative studies. A review may also bring together the findings from quantitative and qualitative studies in a mixed methods or overarching synthesis.[49] The combination of data from a meta-analysis can sometimes be visualised. One method uses a forest plot (also called a blobbogram).[36] In an intervention effect review, the diamond in the 'forest plot' represents the combined results of all the data included.[36] An example of a 'forest plot' is the Cochrane Collaboration logo.[36] The logo is a forest plot of one of the first reviews which showed that corticosteroids given to women who are about to give birth prematurely can save the life of the newborn child.[50]

Recent visualisation innovations include the albatross plot, which plots p-values against sample sizes, with approximate effect-size contours superimposed to facilitate analysis.[51] The contours can be used to infer effect sizes from studies that have been analysed and reported in diverse ways. Such visualisations may have advantages over other types when reviewing complex interventions.

Communication and dissemination

[edit]

Once these stages are complete, the review may be published, disseminated, and translated into practice after being adopted as evidence. The UK National Institute for Health Research (NIHR) defines dissemination as "getting the findings of research to the people who can make use of them to maximise the benefit of the research without delay".[52]

Some users do not have time to invest in reading large and complex documents and/or may lack awareness or be unable to access newly published research. Researchers are, therefore, developing skills to use creative communication methods such as illustrations, blogs, infographics, and board games to share the findings of systematic reviews.[53]

Automation

[edit]

Living systematic reviews are a newer kind of semi-automated, up-to-date online summaries of research that are updated as new research becomes available.[54] The difference between a living systematic review and a conventional systematic review is the publication format. Living systematic reviews are "dynamic, persistent, online-only evidence summaries, which are updated rapidly and frequently".[55]

The automation or semi-automation of the systematic process itself is increasingly being explored. While little evidence exists to demonstrate it is as accurate or involves less manual effort, efforts that promote training and using artificial intelligence for the process are increasing.[56][54]

Research fields

[edit]

Health and medicine

[edit]

Current use of systematic reviews in medicine

[edit]

Many organisations around the world use systematic reviews, with the methodology depending on the guidelines being followed. Organisations which use systematic reviews in medicine and human health include the National Institute for Health and Care Excellence (NICE, UK), the Agency for Healthcare Research and Quality (AHRQ, US), and the World Health Organization. Most notable among international organisations is Cochrane, a group of over 37,000 specialists in healthcare who systematically review randomised trials of the effects of prevention, treatments, and rehabilitation as well as health systems interventions. They sometimes also include the results of other types of research. Cochrane Reviews are published in The Cochrane Database of Systematic Reviews section of the Cochrane Library. The 2015 impact factor for The Cochrane Database of Systematic Reviews was 6.103, and it was ranked 12th in the Medicine, General & Internal category.[57]

There are several types of systematic reviews, including:[58][59][60][61]

  1. Intervention reviews assess the benefits and harms of interventions used in healthcare and health policy.
  2. Diagnostic test accuracy reviews assess how well a diagnostic test performs in diagnosing and detecting a particular disease. For conducting diagnostic test accuracy reviews, free software such as MetaDTA and CAST-HSROC in the graphical user interface is available.[62][63]
  3. Methodology reviews address issues relevant to how systematic reviews and clinical trials are conducted and reported.
  4. Qualitative reviews synthesize qualitative evidence to address questions on aspects other than effectiveness.
  5. Prognosis reviews address the probable course or future outcome(s) of people with a health problem.
  6. Overviews of Systematic Reviews (OoRs) compile multiple pieces of evidence from systematic reviews into a single accessible document, sometimes referred to as umbrella reviews.
  7. Living systematic reviews are continually updated, incorporating relevant new evidence as it becomes available.[64]
  8. Rapid reviews are a form of knowledge synthesis that "accelerates the process of conducting a traditional systematic review through streamlining or omitting specific methods to produce evidence for stakeholders in a resource-efficient manner".[65]
  9. Reviews of complex health interventions in complex systems are to improve evidence synthesis and guideline development.[66]

Patient and public involvement in systematic reviews

[edit]
Further information: Patient and public involvement

There are various ways patients and the public can be involved in producing systematic reviews and other outputs. Tasks for public members can be organised as 'entry level' or higher. Tasks include:

  • Joining a collaborative volunteer effort to help categorise and summarise healthcare evidence[67]
  • Data extraction and risk of bias assessment
  • Translation of reviews into other languages

A systematic review of how people were involved in systematic reviews aimed to document the evidence-base relating to stakeholder involvement in systematic reviews and to use this evidence to describe how stakeholders have been involved in systematic reviews.[68] Thirty percent involved patients and/or carers. The ACTIVE framework provides a way to describe how people are involved in systematic review and may be used as a way to support systematic review authors in planning people's involvement.[69] Standardised Data on Initiatives (STARDIT) is another proposed way of reporting who has been involved in which tasks during research, including systematic reviews.[70][71]

There has been some criticism of how Cochrane prioritises systematic reviews.[72] Cochrane has a project that involved people in helping identify research priorities to inform Cochrane Reviews.[73][74] In 2014, the Cochrane–Wikipedia partnership was formalised.[75]

Environmental health and toxicology

[edit]

Systematic reviews are a relatively recent innovation in the field of environmental health and toxicology. Although mooted in the mid-2000s, the first full frameworks for conduct of systematic reviews of environmental health evidence were published in 2014 by the US National Toxicology Program's Office of Health Assessment and Translation[76] and the Navigation Guide at the University of California San Francisco's Program on Reproductive Health and the Environment.[77] Uptake has since been rapid, with the estimated number of systematic reviews in the field doubling since 2016 and the first consensus recommendations on best practice, as a precursor to a more general standard, being published in 2020.[78]

Social, behavioural, and educational

[edit]

In 1959, social scientist and social work educator Barbara Wootton published one of the first contemporary systematic reviews of literature on anti-social behavior as part of her work, Social Science and Social Pathology.[79][80]

Several organisations use systematic reviews in social, behavioural, and educational areas of evidence-based policy, including the National Institute for Health and Care Excellence (NICE, UK), Social Care Institute for Excellence (SCIE, UK), the Agency for Healthcare Research and Quality (AHRQ, US), the World Health Organization, the International Initiative for Impact Evaluation (3ie), the Joanna Briggs Institute, and the Campbell Collaboration. The quasi-standard for systematic review in the social sciences is based on the procedures proposed by the Campbell Collaboration, which is one of several groups promoting evidence-based policy in the social sciences.[81]

Others

[edit]

Some attempts to transfer the procedures from medicine to business research have been made,[82] including a step-by-step approach,[83][84] and developing a standard procedure for conducting systematic literature reviews in business and economics.

Systematic reviews are increasingly prevalent in other fields, such as international development research.[85] Subsequently, several donors (including the UK Department for International Development (DFID) and AusAid) are focusing more on testing the appropriateness of systematic reviews in assessing the impacts of development and humanitarian interventions.[85]

The Collaboration for Environmental Evidence (CEE) has a journal titled Environmental Evidence, which publishes systematic reviews, review protocols, and systematic maps on the impacts of human activity and the effectiveness of management interventions.[86]

Review tools

[edit]

A 2022 publication identified 24 systematic review tools and ranked them by inclusion of 30 features deemed most important when performing a systematic review in accordance with best practices. The top six software tools (with at least 21/30 key features) are all proprietary paid platforms, typically web-based, and include:[87]

  • Giotto Compliance
  • DistillerSR
  • Nested Knowledge
  • EPPI-Reviewer Web
  • LitStream
  • JBI SUMARI

The Cochrane Collaboration provides a handbook for systematic reviewers of interventions which "provides guidance to authors for the preparation of Cochrane Intervention reviews."[38] The Cochrane Handbook also outlines steps for preparing a systematic review[38] and forms the basis of two sets of standards for the conduct and reporting of Cochrane Intervention Reviews (MECIR; Methodological Expectations of Cochrane Intervention Reviews).[88] It also contains guidance on integrating patient-reported outcomes into reviews.

Limitations

[edit]

Out-dated or risk of bias

[edit]

While systematic reviews are regarded as the strongest form of evidence, a 2003 review of 300 studies found that not all systematic reviews were equally reliable, and that their reporting can be improved by a universally agreed upon set of standards and guidelines.[89] A further study by the same group found that of 100 systematic reviews monitored, 7% needed updating at the time of publication, another 4% within a year, and another 11% within 2 years; this figure was higher in rapidly changing fields of medicine, especially cardiovascular medicine.[90] A 2003 study suggested that extending searches beyond major databases, perhaps into grey literature, would increase the effectiveness of reviews.[91]

Some authors have highlighted problems with systematic reviews, particularly those conducted by Cochrane, noting that published reviews are often biased, out of date, and excessively long.[92] Cochrane reviews have been criticized as not being sufficiently critical in the selection of trials and including too many of low quality. They proposed several solutions, including limiting studies in meta-analyses and reviews to registered clinical trials, requiring that original data be made available for statistical checking, paying greater attention to sample size estimates, and eliminating dependence on only published data. Some of these difficulties were noted as early as 1994:

much poor research arises because researchers feel compelled for career reasons to carry out research that they are ill-equipped to perform, and nobody stops them.

— Altman DG, 1994[93]

Methodological limitations of meta-analysis have also been noted.[94] Another concern is that the methods used to conduct a systematic review are sometimes changed once researchers see the available trials they are going to include.[95] Some websites have described retractions of systematic reviews and published reports of studies included in published systematic reviews.[96][97][98] Eligibility criteria that is arbitrary may affect the perceived quality of the review.[99][100]

Limited reporting of data from human studies

[edit]

The AllTrials campaign report that around half of clinical trials have never reported results and works to improve reporting.[101] 'Positive' trials were twice as likely to be published as those with 'negative' results.[102]

As of 2016, it is legal for-profit companies to conduct clinical trials and not publish the results.[103] For example, in the past 10 years, 8.7 million patients have taken part in trials that have not published results.[103] These factors mean that it is likely there is a significant publication bias, with only 'positive' or perceived favourable results being published. A recent systematic review of industry sponsorship and research outcomes concluded that "sponsorship of drug and device studies by the manufacturing company leads to more favorable efficacy results and conclusions than sponsorship by other sources" and that the existence of an industry bias that cannot be explained by standard 'risk of bias' assessments.[104]

Poor compliance with review reporting guidelines

[edit]

The rapid growth of systematic reviews in recent years has been accompanied by the attendant issue of poor compliance with guidelines, particularly in areas such as declaration of registered study protocols, funding source declaration, risk of bias data, issues resulting from data abstraction, and description of clear study objectives.[105][106][107][108][109] A host of studies have identified weaknesses in the rigour and reproducibility of search strategies in systematic reviews.[110][111][112][113][114][115] To remedy this issue, a new PRISMA guideline extension called PRISMA-S is being developed.[116] Furthermore, tools and checklists for peer-reviewing search strategies have been created, such as the Peer Review of Electronic Search Strategies (PRESS) guidelines.[117]

A key challenge for using systematic reviews in clinical practice and healthcare policy is assessing the quality of a given review. Consequently, a range of appraisal tools to evaluate systematic reviews have been designed. The two most popular measurement instruments and scoring tools for systematic review quality assessment are AMSTAR 2 (a measurement tool to assess the methodological quality of systematic reviews)[118][119][120] and ROBIS (Risk Of Bias In Systematic reviews); however, these are not appropriate for all systematic review types.[121] Some recent peer-reviewed articles have carried out comparisons between AMSTAR 2 and ROBIS tools.[122][123]

History

[edit]

The first publication that is now recognized as equivalent to a modern systematic review was a 1753 paper by James Lind, which reviewed all of the previous publications about scurvy.[124] Systematic reviews appeared only sporadically until the 1980s, and became common after 2000.[124] More than 10,000 systematic reviews are published each year.[124]

History in medicine

[edit]

A 1904 British Medical Journal paper by Karl Pearson collated data from several studies in the UK, India and South Africa of typhoid inoculation. He used a meta-analytic approach to aggregate the outcomes of multiple clinical studies.[125] In 1972, Archie Cochrane wrote: "It is surely a great criticism of our profession that we have not organised a critical summary, by specialty or subspecialty, adapted periodically, of all relevant randomised controlled trials".[126] Critical appraisal and synthesis of research findings in a systematic way emerged in 1975 under the term 'meta analysis'.[127][128] Early syntheses were conducted in broad areas of public policy and social interventions, with systematic research synthesis applied to medicine and health.[129] Inspired by his own personal experiences as a senior medical officer in prisoner of war camps, Archie Cochrane worked to improve the scientific method in medical evidence.[130] His call for the increased use of randomised controlled trials and systematic reviews led to the creation of The Cochrane Collaboration,[131] which was founded in 1993 and named after him, building on the work by Iain Chalmers and colleagues in the area of pregnancy and childbirth.[132][126]

See also

[edit]

References

[edit]

This article was submitted to WikiJournal of Medicine for external academic peer review in 2019 (reviewer reports). The updated content was reintegrated into the Wikipedia page under a CC-BY-SA-3.0 license (2020). The version of record as reviewed is: Jack Nunn; Steven Chang; et al. (9 November 2020). "What are Systematic Reviews?" (PDF). WikiJournal of Medicine. 7 (1): 5. doi:10.15347/WJM/2020.005. ISSN 2002-4436. Wikidata Q99440266. STARDIT report Q101116128.

  1. ^ a b c d "What is a systematic review?". Temple University Libraries. 6 June 2022. Retrieved 15 June 2022.
  2. ^ Armstrong R, Hall BJ, Doyle J, Waters E (March 2011). "Cochrane Update. 'Scoping the scope' of a cochrane review". Journal of Public Health. 33 (1): 147–150. doi:10.1093/pubmed/fdr015. PMID 21345890.
  3. ^ "What is EBM?". Centre for Evidence Based Medicine. 20 November 2009. Archived from the original on 6 April 2011. Retrieved 17 June 2011.
  4. ^ Ader HJ, Mellenbergh GJ, Hand DJ (2008). "Methodological quality". Advising on Research Methods: A consultant's companion. Johannes van Kessel Publishing. ISBN 978-90-79418-02-2.
  5. ^ Bilotta GS, Milner AM, Boyd I (2014). "On the use of systematic reviews to inform environmental policies". Environmental Science & Policy. 42: 67–77. Bibcode:2014ESPol..42...67B. doi:10.1016/j.envsci.2014.05.010.
  6. ^ Systematic reviews: CRD's guidance for undertaking reviews in health care (PDF). York: University of York, Centre for Reviews and Dissemination. 2008. ISBN 978-1-900640-47-3. Retrieved 17 June 2011.
  7. ^ Petticrew M, Roberts H (2006). Systematic reviews in the social sciences (PDF). Wiley Blackwell. ISBN 978-1-4051-2110-1. Archived from the original (PDF) on 16 June 2015.
  8. ^ Bearman M, Dawson P (March 2013). "Qualitative synthesis and systematic review in health professions education". Medical Education. 47 (3): 252–260. doi:10.1111/medu.12092. PMID 23398011. S2CID 11042748.
  9. ^ Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. (20 September 2019). Cochrane Handbook for Systematic Reviews of Interventions. version 6.1. pp. section 4.6. Retrieved 14 September 2020. {{cite book}}: |website= ignored (help)
  10. ^ Siemieniuk R, Guyatt G. "What is GRADE?". BMJ Best Practice. Retrieved 26 August 2020.
  11. ^ Adèr HJ (2008). Advising on Research Methods: A Consultant's Companion. Johannes van Kessel Publishing. ISBN 978-90-79418-01-5.
  12. ^ Schünemann H, Brożek J, Guyatt G, Oxman A, eds. (2013). GRADE Handbook. Retrieved 26 August 2020.
  13. ^ a b Flemming K, Booth A, Hannes K, Cargo M, Noyes J (May 2018). "Cochrane Qualitative and Implementation Methods Group guidance series-paper 6: reporting guidelines for qualitative, implementation, and process evaluation evidence syntheses" (PDF). Journal of Clinical Epidemiology. 97: 79–85. doi:10.1016/j.jclinepi.2017.10.022. PMID 29222060.
  14. ^ Harden A, Thomas J, Cargo M, Harris J, Pantoja T, Flemming K, et al. (May 2018). "Cochrane Qualitative and Implementation Methods Group guidance series-paper 5: methods for integrating qualitative and implementation evidence within intervention effectiveness reviews" (PDF). Journal of Clinical Epidemiology. 97: 70–78. doi:10.1016/j.jclinepi.2017.11.029. PMID 29242095.
  15. ^ "EPPI-Centre Home". eppi.ioe.ac.uk. Retrieved 29 June 2020.
  16. ^ a b Booth A, Noyes J, Flemming K, Gerhardus A, Wahlster P, Van Der Wilt GJ, et al. (2016). Guidance on choosing qualitative evidence synthesis methods for use in health technology assessments of complex interventions. p. 32. OCLC 944453327.
  17. ^ a b c d e f g Grant MJ, Booth A (June 2009). "A typology of reviews: an analysis of 14 review types and associated methodologies". Health Information and Libraries Journal. 26 (2): 91–108. doi:10.1111/j.1471-1842.2009.00848.x. PMID 19490148.
  18. ^ Page, Matthew J.; McKenzie, Joanne E.; Bossuyt, Patrick M.; Boutron, Isabelle; Hoffmann, Tammy C.; Mulrow, Cynthia D.; Shamseer, Larissa; Tetzlaff, Jennifer M.; Akl, Elie A.; Brennan, Sue E.; Chou, Roger; Glanville, Julie; Grimshaw, Jeremy M.; Hróbjartsson, Asbjørn; Lalu, Manoj M. (29 March 2021). "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews". BMJ (Clinical Research Ed.). 372: n71. doi:10.1136/bmj.n71. ISSN 1756-1833. PMC 8005924. PMID 33782057.
  19. ^ a b "Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement". www.equator-network.org. Retrieved 29 June 2020.
  20. ^ Topor, Marta; Pickering, Jade S.; Mendes, Ana Barbosa; Bishop, Dorothy V. M.; Büttner, Fionn; Elsherif, Mahmoud M.; Evans, Thomas R.; Henderson, Emma L.; Kalandadze, Tamara; Nitschke, Faye T.; Staaks, Janneke P. C.; Akker, Olmo R. van den; Yeung, Siu Kit; Zaneva, Mirela; Lam, Alison (10 July 2023). "An integrative framework for planning and conducting Non-Intervention, Reproducible, and Open Systematic Reviews (NIRO-SR)". Meta-Psychology. 7. doi:10.15626/MP.2021.2840. hdl:11250/3106491. ISSN 2003-2714.
  21. ^ Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R (May 2013). "RAMESES publication standards: meta-narrative reviews". Journal of Advanced Nursing. 69 (5): 987–1004. doi:10.1111/jan.12092. PMC 3558334. PMID 23356699.
  22. ^ Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R (May 2013). "RAMESES publication standards: realist syntheses". Journal of Advanced Nursing. 69 (5): 1005–1022. doi:10.1111/jan.12095. PMC 3558331. PMID 23356726.
  23. ^ a b Arksey H, O'Malley L (2005). "Scoping studies: Towards a methodological framework" (PDF). International Journal of Social Research Methodology. 8: 19–32. doi:10.1080/1364557032000119616. hdl:11250/2477738. S2CID 12719181.
  24. ^ a b "PRISMA". www.prisma-statement.org. Retrieved 1 July 2020.
  25. ^ "What is a rapid review? Systematic Review Library Guides at CQ University". library.cqu.edu.au. Archived from the original on 16 September 2020. Retrieved 16 September 2020.
  26. ^ "Home". covidrapidreviews.cochrane.org. Retrieved 1 July 2020.
  27. ^ a b c Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB (September 2015). "Guidance for conducting systematic scoping reviews". International Journal of Evidence-Based Healthcare. 13 (3): 141–146. doi:10.1097/XEB.0000000000000050. PMID 26134548. S2CID 8860037.
  28. ^ a b Levac D, Colquhoun H, O'Brien KK (September 2010). "Scoping studies: advancing the methodology". Implementation Science. 5 (1): 69. doi:10.1186/1748-5908-5-69. PMC 2954944. PMID 20854677.
  29. ^ a b Colquhoun HL, Levac D, O'Brien KK, Straus S, Tricco AC, Perrier L, et al. (December 2014). "Scoping reviews: time for clarity in definition, methods, and reporting". Journal of Clinical Epidemiology. 67 (12): 1291–1294. doi:10.1016/j.jclinepi.2014.03.013. hdl:1807/73365. PMID 25034198. S2CID 205843946.
  30. ^ Nunn JS, Tiller J, Fransquet P, Lacaze P (2019). "Public Involvement in Global Genomics Research: A Scoping Review". Frontiers in Public Health. 7: 79. doi:10.3389/fpubh.2019.00079. PMC 6467093. PMID 31024880.
  31. ^ a b Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, et al. (21 April 2017). "Stakeholder involvement in systematic reviews: a protocol for a systematic review of methods, outcomes and effects". Research Involvement and Engagement. 3 (1): 9. doi:10.1186/s40900-017-0060-4. PMC 5611627. PMID 29062534.
  32. ^ Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris E (November 2018). "Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach". BMC Medical Research Methodology. 18 (1): 143. doi:10.1186/s12874-018-0611-x. PMC 6245623. PMID 30453902.
  33. ^ Arksey H, O'Malley L (1 February 2005). "Scoping studies: towards a methodological framework" (PDF). International Journal of Social Research Methodology. 8 (1): 19–32. doi:10.1080/1364557032000119616. hdl:11250/2477738. S2CID 12719181.
  34. ^ Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. (October 2018). "PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation" (PDF). Annals of Internal Medicine. 169 (7): 467–473. doi:10.7326/M18-0850. PMID 30178033. S2CID 52150954.
  35. ^ "PROSPERO". Centre for Reviews and Dissemination. University of York. Retrieved 24 February 2019.
  36. ^ a b c d e f g "Animated Storyboard: What Are Systematic Reviews?". cccrg.cochrane.org. Cochrane Consumers and Communication. Retrieved 1 June 2016.
  37. ^ Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. (January 2015). "Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement". Systematic Reviews. 4 (1): 1. doi:10.1186/2046-4053-4-1. PMC 4320440. PMID 25554246.
  38. ^ a b c Higgins JP, Green S (eds.). "Cochrane handbook for systematic reviews of interventions, version 5.1.0 (updated March 2011)". The Cochrane Collaboration. Retrieved 2 June 2016.
  39. ^ "5. Handsearching". training.cochrane.org. Retrieved 14 September 2020.
  40. ^ Papaioannou D, Sutton A, Carroll C, Booth A, Wong R (June 2010). "Literature searching for social science systematic reviews: consideration of a range of search techniques". Health Information and Libraries Journal. 27 (2): 114–122. doi:10.1111/j.1471-1842.2009.00863.x. PMID 20565552.
  41. ^ Rethlefsen ML, Farrell AM, Osterhaus Trzasko LC, Brigham TJ (June 2015). "Librarian co-authors correlated with higher quality reported search strategies in general internal medicine systematic reviews". Journal of Clinical Epidemiology. 68 (6): 617–626. doi:10.1016/j.jclinepi.2014.11.025. PMID 25766056.
  42. ^ Koffel JB (4 May 2015). "Use of recommended search strategies in systematic reviews and the impact of librarian involvement: a cross-sectional survey of recent authors". PLOS ONE. 10 (5): e0125931. Bibcode:2015PLoSO..1025931K. doi:10.1371/journal.pone.0125931. PMC 4418838. PMID 25938454.
  43. ^ Meert D, Torabi N, Costella J (October 2016). "Impact of librarians on reporting of the literature searching component of pediatric systematic reviews". Journal of the Medical Library Association. 104 (4): 267–277. doi:10.5195/jmla.2016.139. PMC 5079487. PMID 27822147.
  44. ^ Li L, Tian J, Tian H, Moher D, Liang F, Jiang T, et al. (September 2014). "Network meta-analyses could be improved by searching more sources and by involving a librarian". Journal of Clinical Epidemiology. 67 (9): 1001–1007. doi:10.1016/j.jclinepi.2014.04.003. PMID 24841794.
  45. ^ Rethlefsen ML, Murad MH, Livingston EH (September 2014). "Engaging medical librarians to improve the quality of review articles". JAMA. 312 (10): 999–1000. doi:10.1001/jama.2014.9263. PMID 25203078.
  46. ^ a b "Animated Storyboard: What Are Systematic Reviews?". cccrg.cochrane.org. Retrieved 24 November 2020.
  47. ^ Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. (20 September 2019). "Chapter 4: Searching for and selecting studies". Cochrane Handbook for Systematic Reviews of Interventions. version 6.1. section 4.6. Retrieved 14 September 2020. {{cite book}}: |website= ignored (help)
  48. ^ Marshall C, Brereton P (27 April 2015). "Systematic review toolbox". Proceedings of the 19th International Conference on Evaluation and Assessment in Software Engineering. EASE '15. Nanjing, China: Association for Computing Machinery. pp. 1–6. doi:10.1145/2745802.2745824. ISBN 978-1-4503-3350-4. S2CID 6679820.
  49. ^ Thompson Coon J, Gwernan-Jones R, Garside R, Nunns M, Shaw L, Melendez-Torres GJ, Moore D (July 2020). "Developing methods for the overarching synthesis of quantitative and qualitative evidence: The interweave synthesis approach". Research Synthesis Methods. 11 (4): 507–521. doi:10.1002/jrsm.1383. PMC 7383598. PMID 31725951.
  50. ^ "The difference we make". www.cochrane.org. Retrieved 8 March 2019.
  51. ^ Higgins JP, López-López JA, Becker BJ, Davies SR, Dawson S, Grimshaw JM, et al. (1 January 2019). "Synthesising quantitative evidence in systematic reviews of complex health interventions". BMJ Global Health. 4 (Suppl 1): e000858. doi:10.1136/bmjgh-2018-000858. PMC 6350707. PMID 30775014.
  52. ^ "How to disseminate your research". www.nihr.ac.uk. Retrieved 20 May 2022.
  53. ^ Coon JT, Orr N, Shaw L, Hunt H, Garside R, Nunns M, et al. (April 2022). "Bursting out of our bubble: using creative techniques to communicate within the systematic review process and beyond". Systematic Reviews. 11 (1): 56. doi:10.1186/s13643-022-01935-2. PMC 8977563. PMID 35379331.
  54. ^ a b Tsafnat G, Glasziou P, Choong MK, Dunn A, Galgani F, Coiera E (July 2014). "Systematic review automation technologies". Systematic Reviews. 3 (1): 74. doi:10.1186/2046-4053-3-74. PMC 4100748. PMID 25005128.
  55. ^ Elliott JH, Turner T, Clavisi O, Thomas J, Higgins JP, Mavergames C, Gruen RL (February 2014). "Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap". PLOS Medicine. 11 (2): e1001603. doi:10.1371/journal.pmed.1001603. PMC 3928029. PMID 24558353.
  56. ^ Reddy SM, Patel S, Weyrich M, Fenton J, Viswanathan M (October 2020). "Comparison of a traditional systematic review approach with review-of-reviews and semi-automation as strategies to update the evidence". Systematic Reviews. 9 (1): 243. doi:10.1186/s13643-020-01450-2. PMC 7574591. PMID 33076975.
  57. ^ The Cochrane Library. 2015 impact factor. Cochrane Database of Systematic Reviews (CDSR) Archived 2 July 2016 at the Wayback Machine Retrieved 2016-07-20.
  58. ^ Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
  59. ^ "Main page". Cochrane Library.
  60. ^ Silva V, Grande AJ, Carvalho AP, Martimbianco AL, Riera R (2015). "Overview of systematic reviews - a new type of study. Part II". Sao Paulo Medical Journal = Revista Paulista de Medicina. 133 (3): 206–217. doi:10.1590/1516-3180.2013.8150015. PMC 10876375. PMID 25388685.
  61. ^ Silva V, Grande AJ, Martimbianco AL, Riera R, Carvalho AP (2012). "Overview of systematic reviews - a new type of study: part I: why and for whom?". Sao Paulo Medical Journal = Revista Paulista de Medicina. 130 (6): 398–404. doi:10.1590/S1516-31802012000600007. PMC 10522321. PMID 23338737.
  62. ^ Freeman SC, Kerby CR, Patel A, Cooper NJ, Quinn T, Sutton AJ (April 2019). "Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA". BMC Medical Research Methodology. 19 (1): 81. doi:10.1186/s12874-019-0724-x. PMC 6471890. PMID 30999861.
  63. ^ Banno M, Tsujimoto Y, Luo Y, Miyakoshi C, Kataoka Y (February 2021). "CAST-HSROC: A Web Application for Calculating the Summary Points of Diagnostic Test Accuracy From the Hierarchical Summary Receiver Operating Characteristic Model". Cureus. 13 (2): e13257. doi:10.7759/cureus.13257. PMC 7953362. PMID 33717762.
  64. ^ "Living systematic reviews". community.cochrane.org. Retrieved 1 July 2020.
  65. ^ "Cochrane's work on Rapid Reviews in response to COVID-19". www.cochrane.org. Retrieved 1 July 2020.
  66. ^ Norris SL, Rehfuess EA, Smith H, Tunçalp Ö, Grimshaw JM, Ford NP, Portela A (1 January 2019). "Complex health interventions in complex systems: improving the process and methods for evidence-informed health decisions". BMJ Global Health. 4 (Suppl 1): e000963. doi:10.1136/bmjgh-2018-000963. PMC 6350736. PMID 30775018.
  67. ^ "Cochrane crowd". crowd.cochrane.org. Retrieved 14 February 2019.
  68. ^ Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, et al. (November 2018). "Stakeholder involvement in systematic reviews: a scoping review". Systematic Reviews. 7 (1): 208. doi:10.1186/s13643-018-0852-0. PMC 6260873. PMID 30474560.
  69. ^ Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, et al. (October 2019). "Development of the ACTIVE framework to describe stakeholder involvement in systematic reviews" (PDF). Journal of Health Services Research & Policy. 24 (4): 245–255. doi:10.1177/1355819619841647. PMID 30997859. S2CID 121348214.
  70. ^ [Pre-print] Nunn J, Shafee T, Chang S, Stephens R, Elliott J, Oliver S, John D, Smith M, Orr N. "Standardised Data on Initiatives - STARDIT: Alpha Version". osf.io. doi:10.31219/osf.io/5q47h. S2CID 242815262. Retrieved 20 August 2020.
  71. ^ Nunn JS, Shafee T, Chang S, Stephens R, Elliott J, Oliver S, et al. (July 2022). "Standardised data on initiatives-STARDIT: Beta version". Research Involvement and Engagement. 8 (1): 31. doi:10.1186/s40900-022-00363-9. PMC 9294764. PMID 35854364.
  72. ^ Newman, Melanie (3 January 2019). "Has Cochrane lost its way?". BMJ. 364: k5302. doi:10.1136/bmj.k5302. PMID 30606713. S2CID 58623482.
  73. ^ Synnot AJ, Tong A, Bragge P, Lowe D, Nunn JS, O'Sullivan M, et al. (April 2019). "Selecting, refining and identifying priority Cochrane Reviews in health communication and participation in partnership with consumers and other stakeholders". Health Research Policy and Systems. 17 (1): 45. doi:10.1186/s12961-019-0444-z. PMC 6489310. PMID 31036016.
  74. ^ Synnot A, Bragge P, Lowe D, Nunn JS, O'Sullivan M, Horvat L, et al. (May 2018). "Research priorities in health communication and participation: international survey of consumers and other stakeholders". BMJ Open. 8 (5): e019481. doi:10.1136/bmjopen-2017-019481. PMC 5942413. PMID 29739780.
  75. ^ "The Cochrane-Wikipedia partnership in 2016". Cochrane. Retrieved 24 February 2019.
  76. ^ Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA (July 2014). "Systematic review and evidence integration for literature-based environmental health science assessments". Environmental Health Perspectives. 122 (7): 711–718. Bibcode:2014EnvHP.122..711R. doi:10.1289/ehp.1307972. PMC 4080517. PMID 24755067.
  77. ^ Woodruff TJ, Sutton P (October 2014). "The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes". Environmental Health Perspectives. 122 (10): 1007–1014. Bibcode:2014EnvHP.122.1007W. doi:10.1289/ehp.1307175. PMC 4181919. PMID 24968373.
  78. ^ Whaley P, Aiassa E, Beausoleil C, Beronius A, Bilotta G, Boobis A, et al. (October 2020). "Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER)". Environment International. 143: 105926. Bibcode:2020EnInt.14305926W. doi:10.1016/j.envint.2020.105926. hdl:2066/229303. PMID 32653802. S2CID 220502683.
  79. ^ Gough D, Oliver S, Thomas J (2017). An Introduction to Systematic Reviews (2nd ed.). London: Sage. p. XIII.
  80. ^ Oakley A (2011). A critical woman : Barbara Wootton, social science and public policy in the twentieth century. London: Bloomsbury Academic. ISBN 9781849664707.
  81. ^ "History of the Campbell Collaboration". Campbell Collaboration. Retrieved 15 April 2021.
  82. ^ Tranfield D, Denyer D, Smart P (2003). "Towards a methodology for developing evidence-informed management knowledge by means of systematic review". British Journal of Management. 14 (3): 207–222. CiteSeerX 10.1.1.622.895. doi:10.1111/1467-8551.00375.
  83. ^ Durach CF, Kembro J, Wieland A (2017). "A New Paradigm for Systematic Literature Reviews in Supply Chain Management". Journal of Supply Chain Management. 53 (4): 67–85. doi:10.1111/jscm.12145.
  84. ^ Linnenluecke, Martina K; Marrone, Mauricio; Singh, Abhay K (May 2020). "Conducting systematic literature reviews and bibliometric analyses". Australian Journal of Management. 45 (2): 175–194. doi:10.1177/0312896219877678. ISSN 0312-8962.
  85. ^ a b Hagen-Zanker J, Duvendack M, Mallett R, Slater R, Carpenter S, Tromme M (January 2012). "Making systematic reviews work for international development research". Overseas Development Institute.
  86. ^ "Environmental Evidence: Reliable evidence, informed decisions, better environment". www.environmentalevidence.org. Retrieved 1 July 2020.
  87. ^ Cowie K, Rahmatullah A, Hardy N, Holub K, Kallmes K (2022). "Web-Based Software Tools for Systematic Literature Review in Medicine: Systematic Search and Feature Analysis". JMIR. 10 (5): e33219. doi:10.2196/33219. PMC 9112080. PMID 35499859.
  88. ^ "Methodological Expectations of Cochrane Intervention Reviews (MECIR)". Cochrane. Retrieved 6 October 2014.
  89. ^ Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (March 2007). "Epidemiology and reporting characteristics of systematic reviews". PLOS Medicine. 4 (3): e78. doi:10.1371/journal.pmed.0040078. PMC 1831728. PMID 17388659.
  90. ^ Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D (August 2007). "How quickly do systematic reviews go out of date? A survival analysis". Annals of Internal Medicine. 147 (4): 224–233. doi:10.7326/0003-4819-147-4-200708210-00179. PMID 17638714. S2CID 3988259.
  91. ^ Savoie I, Helmer D, Green CJ, Kazanjian A (2003). "Beyond Medline: reducing bias through extended systematic review search". International Journal of Technology Assessment in Health Care. 19 (1): 168–178. doi:10.1017/S0266462303000163. PMID 12701949. S2CID 42494895.
  92. ^ Roberts I, Ker K, Edwards P, Beecher D, Manno D, Sydenham E (June 2015). "The knowledge system underpinning healthcare is not fit for purpose and must change" (PDF). BMJ. 350: h2463. doi:10.1136/bmj.h2463. PMID 26041754. S2CID 33523612.
  93. ^ Altman DG (January 1994). "The scandal of poor medical research". BMJ. 308 (6924): 283–284. doi:10.1136/bmj.308.6924.283. PMC 2539276. PMID 8124111.
  94. ^ Shapiro S (November 1994). "Meta-analysis/Shmeta-analysis". American Journal of Epidemiology. 140 (9): 771–778. doi:10.1093/oxfordjournals.aje.a117324. PMID 7977286.
  95. ^ Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A (October 2014). "Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions". The Cochrane Database of Systematic Reviews. 2015 (10): MR000035. doi:10.1002/14651858.MR000035.pub2. PMC 8191366. PMID 25271098.
  96. ^ Roberts I (12 June 2015). "Retraction Of Scientific Papers For Fraud Or Bias Is Just The Tip Of The Iceberg". IFL Science!. Retrieved 29 June 2015.
  97. ^ Ferguson C (2 April 2015). "Retraction and republication for Lancet Resp Med tracheostomy paper". Retraction Watch. Retrieved 29 June 2015.
  98. ^ Ferguson C (26 March 2015). "BioMed Central retracting 43 papers for fake peer review". Retraction Watch.
  99. ^ Flinders University Library. "Search Smart: Systematic Reviews: Methodology overview". flinders.libguides.com. Retrieved 16 September 2020.
  100. ^ Pursell E, McCrae N (2020). How to Perform a Systematic Literature Review: a guide for healthcare researchers, practitioners and students. Springer Nature. ISBN 978-3-030-49672-2. OCLC 1182880684.
  101. ^ "Half of all clinical trials have never reported results". AllTrials. 20 August 2015. Retrieved 8 March 2019.
  102. ^ Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, et al. (February 2010). "Dissemination and publication of research findings: an updated review of related biases". Health Technology Assessment. 14 (8): iii, ix–xi, 1–193. doi:10.3310/hta14080. PMID 20181324.
  103. ^ a b Iacobucci G (November 2016). "Nearly half of all trials run by major sponsors in past decade are unpublished". BMJ. 355: i5955. doi:10.1136/bmj.i5955. PMID 27815253. S2CID 43604202.
  104. ^ Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L, et al. (Cochrane Methodology Review Group) (February 2017). "Industry sponsorship and research outcome". The Cochrane Database of Systematic Reviews. 2017 (2): MR000033. doi:10.1002/14651858.MR000033.pub3. PMC 8132492. PMID 28207928.
  105. ^ Pidgeon TE, Wellstead G, Sagoo H, Jafree DJ, Fowler AJ, Agha RA (October 2016). "An assessment of the compliance of systematic review articles published in craniofacial surgery with the PRISMA statement guidelines: A systematic review". Journal of Cranio-Maxillo-Facial Surgery. 44 (10): 1522–1530. doi:10.1016/j.jcms.2016.07.018. PMID 27575881.
  106. ^ Lee SY, Sagoo H, Whitehurst K, Wellstead G, Fowler AJ, Agha RA, Orgill D (1 March 2016). "Compliance of Systematic Reviews in Plastic Surgery With the PRISMA Statement". JAMA Facial Plastic Surgery. 18 (2): 101–105. doi:10.1001/jamafacial.2015.1726. PMID 26719993.
  107. ^ Akhigbe T, Zolnourian A, Bulters D (May 2017). "Compliance of systematic reviews articles in brain arteriovenous malformation with PRISMA statement guidelines: Review of literature". Journal of Clinical Neuroscience. 39: 45–48. doi:10.1016/j.jocn.2017.02.016. PMID 28246008. S2CID 27738264.
  108. ^ Lee SY, Sagoo H, Farwana R, Whitehurst K, Fowler A, Agha R (December 2017). "Compliance of systematic reviews in ophthalmology with the PRISMA statement". BMC Medical Research Methodology. 17 (1): 178. doi:10.1186/s12874-017-0450-1. PMC 5745614. PMID 29281981.
  109. ^ E JY, Saldanha IJ, Canner J, Schmid CH, Le JT, Li T (May 2020). "Adjudication rather than experience of data abstraction matters more in reducing errors in abstracting data in systematic reviews". Research Synthesis Methods. 11 (3): 354–362. doi:10.1002/jrsm.1396. PMID 31955502. S2CID 210829764.
  110. ^ Koffel JB, Rethlefsen ML (26 September 2016). Thombs BD (ed.). "Reproducibility of Search Strategies Is Poor in Systematic Reviews Published in High-Impact Pediatrics, Cardiology and Surgery Journals: A Cross-Sectional Study". PLOS ONE. 11 (9): e0163309. Bibcode:2016PLoSO..1163309K. doi:10.1371/journal.pone.0163309. PMC 5036875. PMID 27669416.
  111. ^ Yoshii A, Plaut DA, McGraw KA, Anderson MJ, Wellik KE (January 2009). "Analysis of the reporting of search strategies in Cochrane systematic reviews". Journal of the Medical Library Association. 97 (1): 21–29. doi:10.3163/1536-5050.97.1.004. PMC 2605027. PMID 19158999.
  112. ^ Toews LC (July 2017). "Compliance of systematic reviews in veterinary journals with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) literature search reporting guidelines". Journal of the Medical Library Association. 105 (3): 233–239. doi:10.5195/jmla.2017.246. PMC 5490700. PMID 28670210.
  113. ^ Mullins MM, DeLuca JB, Crepaz N, Lyles CM (June 2014). "Reporting quality of search methods in systematic reviews of HIV behavioral interventions (2000-2010): are the searches clearly explained, systematic and reproducible?". Research Synthesis Methods. 5 (2): 116–130. doi:10.1002/jrsm.1098. PMC 5861495. PMID 26052651.
  114. ^ Briscoe S (March 2018). "A review of the reporting of web searching to identify studies for Cochrane systematic reviews". Research Synthesis Methods. 9 (1): 89–99. doi:10.1002/jrsm.1275. PMID 29065246. S2CID 206155997.
  115. ^ Golder S, Loke Y, McIntosh HM (May 2008). "Poor reporting and inadequate searches were apparent in systematic reviews of adverse effects". Journal of Clinical Epidemiology. 61 (5): 440–448. doi:10.1016/j.jclinepi.2007.06.005. PMID 18394536.
  116. ^ Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB (April 2021). "PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews". Journal of the Medical Library Association. 109 (2): 174–200. doi:10.17605/OSF.IO/YGN9W. PMC 8270366. PMID 34285662.
  117. ^ McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C (July 2016). "PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement". Journal of Clinical Epidemiology. 75: 40–46. doi:10.1016/j.jclinepi.2016.01.021. PMID 27005575.
  118. ^ Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. (September 2017). "AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both". BMJ. 358: j4008. doi:10.1136/bmj.j4008. PMC 5833365. PMID 28935701.
  119. ^ Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. (February 2007). "Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews". BMC Medical Research Methodology. 7 (1): 10. doi:10.1186/1471-2288-7-10. PMC 1810543. PMID 17302989.
  120. ^ Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, et al. (October 2009). "AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews". Journal of Clinical Epidemiology. 62 (10): 1013–1020. doi:10.1016/j.jclinepi.2008.10.009. PMID 19230606. S2CID 5935312.
  121. ^ Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. (January 2016). "ROBIS: A new tool to assess risk of bias in systematic reviews was developed". Journal of Clinical Epidemiology. 69: 225–234. doi:10.1016/j.jclinepi.2015.06.005. PMC 4687950. PMID 26092286.
  122. ^ Perry, R.; Whitmarsh, A.; Leach, V.; Davies, P. (25 October 2021). "A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2". Systematic Reviews. 10 (1): 273. doi:10.1186/s13643-021-01819-x. ISSN 2046-4053. PMC 8543959. PMID 34696810.
  123. ^ Pieper, Dawid; Puljak, Livia; González-Lorenzo, Marien; Minozzi, Silvia (April 2019). "Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic reviews including both randomized and nonrandomized studies". Journal of Clinical Epidemiology. 108: 26–33. doi:10.1016/j.jclinepi.2018.12.004. ISSN 1878-5921. PMID 30543911.
  124. ^ a b c Clarke, Mike; Chalmers, Iain (August 2018). "Reflections on the history of systematic reviews". BMJ Evidence-Based Medicine. 23 (4): 121–122. doi:10.1136/bmjebm-2018-110968. ISSN 2515-446X. PMID 29921711. S2CID 49311760.
  125. ^ "Report on Certain Enteric Fever Inoculation Statistics". British Medical Journal. 2 (2288). British Medical Journal Publishing Group: 1243–1246. November 1904. doi:10.1136/bmj.2.2288.1243. PMC 2355479. PMID 20761760. S2CID 30331745.
  126. ^ a b "1.1.2 A brief history of Cochrane". community.cochrane.org. Archived from the original on 17 January 2019. Retrieved 24 February 2019.
  127. ^ Glass GV, Smith ML, et al. (Far West Lab. for Educational Research and Development, San Francisco, CA) (1978). Meta-Analysis of Research on the Relationship of Class-Size and Achievement. The Class Size and Instruction Project. Washington, D.C.]: Distributed by ERIC Clearinghouse.
  128. ^ "History of Systematic Reviews". Evidence for Policy and Practice Information and Co-ordinating Centre (EPPI-Centre). Retrieved 24 February 2019.
  129. ^ Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (July 1992). "Cumulative meta-analysis of therapeutic trials for myocardial infarction". The New England Journal of Medicine. 327 (4): 248–254. doi:10.1056/NEJM199207233270406. PMID 1614465.
  130. ^ Cochrane AL (1972). Effectiveness and efficiency: random reflections on health services (PDF). [London]: Nuffield Provincial Hospitals Trust. ISBN 0-900574-17-8. OCLC 741462. Archived from the original on 16 September 2020.
  131. ^ Shah HM, Chung KC (September 2009). "Archie Cochrane and his vision for evidence-based medicine". Plastic and Reconstructive Surgery. 124 (3): 982–988. doi:10.1097/PRS.0b013e3181b03928. PMC 2746659. PMID 19730323.
  132. ^ Evans I, Thornton H, Chalmers I, Glasziou P (2011). Testing treatments : better research for better healthcare (Second ed.). London: Pinter & Martin. ISBN 978-1-905177-48-6. OCLC 778837501.
[edit]
Wikimedia Commons has media related to Systematic review.
Library resources about
systematic review
Retrieved from "https://en.wikipedia.org/w/index.php?title=Systematic_review&oldid=1256961682"